IRulya Therapeutics IRLA
IRulya Therapeutics updates corporate presentation
Item 7.01 Investor disclosure
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-26-424731
- Posted Corporate Presentation on October 2026
- Presentation available at ir.irulya.com
- CFO signed filing
Written from the 8-K on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Veru VERU public float $64M, Mar 31, 2025, over 18 months old
- Lifevantage LFVN public float $64M, Dec 31, 2025
- Whitehawk Therapeutics WHWK public float $65M, Jun 30, 2025
- Medicinova MNOV public float $62M, Jun 30, 2025
- Corbus Pharmaceuticals Holdings CRBP public float $68M, Jun 30, 2025